Drugs are used for the treatment of asthma in patients aged 12 years and older who are uncontrolled on an inhaled corticosteroid or whose disease severity clearly warrants the use of an ICS/long-acting beta2-adrenergic agonist combination.
Daewoong Pharmaceutical’s Meroprenem is a generic of Merem, developed by AstraZeneca, as a Carbapenem-series antibiotic widely used in hospitals to treat various ailments ranging from bacterial infections to general diseases.
The New York Times is reporting that Philadephia-based generics company Lannett continues to raise prices on its drugs, even as the Justice Department is set to launch an anitrust investigations an Connecticut’s attorney general undertakes a drug price investigation into the company. Among the generics that have seen prices increase recently was anti-psychotic fluphenazine, which went from $43.50 to $870 for 100 10-mg capsules in 2016. (New York Times)